Biophytis Stock Current Liabilities
BPTSDelisted Stock | USD 7.03 0.00 0.00% |
Biophytis fundamentals help investors to digest information that contributes to Biophytis' financial success or failures. It also enables traders to predict the movement of Biophytis Stock. The fundamental analysis module provides a way to measure Biophytis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biophytis stock.
Biophytis |
Biophytis Company Current Liabilities Analysis
Biophytis' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Biophytis has a Current Liabilities of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Biophytis Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biophytis' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics of similar companies.Biophytis is currently under evaluation in current liabilities category among its peers.
Biophytis Fundamentals
Return On Equity | -12.44 | |||
Return On Asset | -0.53 | |||
Current Valuation | 9.73 B | |||
Shares Outstanding | 286.5 K | |||
Shares Owned By Institutions | 0.04 % | |||
Number Of Shares Shorted | 368.95 K | |||
Price To Book | 2.26 X | |||
EBITDA | (15.09 M) | |||
Net Income | (17.03 M) | |||
Cash And Equivalents | 23.93 M | |||
Cash Per Share | 1.71 X | |||
Total Debt | 8.27 M | |||
Debt To Equity | 3.27 % | |||
Current Ratio | 1.37 X | |||
Book Value Per Share | (0) X | |||
Cash Flow From Operations | (13.33 M) | |||
Short Ratio | 0.41 X | |||
Earnings Per Share | (128.39) X | |||
Target Price | 6000.0 | |||
Number Of Employees | 22 | |||
Beta | 1.05 | |||
Market Capitalization | 2.61 M | |||
Total Asset | 11.94 M | |||
Retained Earnings | (19.38 M) | |||
Working Capital | (3.52 M) | |||
Net Asset | 11.94 M |
About Biophytis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biophytis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biophytis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biophytis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |